{"id":"W1976865991","doi":"10.1111/jdv.12934","title":"Improvements in patient‐reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE","year":2015,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; Merck Canada Inc. (Canada); Lynde Centre for Dermatology; Moncton Hospital; Amgen (Canada); Centre de Recherche Dermatologique du Québec Métropolitain; Innovaderm (Canada); Probity Medical Research","funders":"Pfizer; Amgen","keywords":"Etanercept; Medicine; Dermatology Life Quality Index; Psoriasis; Internal medicine; Randomized controlled trial; Dermatology; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002666504,0.0002606967,0.0009561299,0.0002961939,0.0001199363,0.0003636109,0.0002490985,0.0002856576,0.00170751],"category_scores_gemma":[0.00433282,0.0001582943,0.001444487,0.0004285149,0.0002596383,0.0003143564,0.0003047092,0.0004689133,0.0001970215],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000350326,"about_ca_system_score_gemma":0.0003473332,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008564391,"about_ca_topic_score_gemma":0.001747511,"domain_scores_codex":[0.9986933,0.0006420603,0.0001529034,0.0001191244,0.0003067373,0.00008599622],"domain_scores_gemma":[0.9958432,0.001736832,0.001444257,0.0003619369,0.0003680063,0.0002457215],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2939125,0.005826778,0.4234918,0.00232842,0.008205855,0.0001620967,0.0006910017,0.002233339,0.01119617,0.0001728659,0.00152653,0.2502525],"study_design_scores_gemma":[0.02718079,0.06583186,0.8944709,0.0001680713,0.004881316,0.0004156017,0.000236976,0.0008782335,0.002214828,0.00009813426,0.003574181,0.00004915216],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967775,0.00187143,0.0001263202,0.00006418551,0.000007813873,0.00008217027,0.0003901616,0.000007138945,0.0006732123],"genre_scores_gemma":[0.9981578,0.0007813062,0.0002773107,0.00008447099,0.00002678094,0.00005442313,0.0004391638,0.000002524391,0.0001761934],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002666504,"threshold_uncertainty_score":0.01410198,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02378567879713218,"score_gpt":0.2445136708240765,"score_spread":0.2207279920269443,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}